Abou-Alfa GK, Meyer T, Cheng AL, et al. Cabozantinib in patients with advanced, progressing hepatocellular carcinoma. N Engl J Med. 2018, 379(1):54-63. doi: 10.1056/NEJMoa1717002.
Advertisement
Articles by Abou-Alfa GK, Meyer T, Cheng AL, et al. Cabozantinib in patients with advanced, progressing hepatocellular carcinoma. N Engl J Med. 2018, 379(1):54-63. doi: 10.1056/NEJMoa1717002.
Advertisement
Latest Updated Articles
- Study Summary: Cabozantinib for Advanced and Progressing Hepatocellular Carcinoma
Published: November 9th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Prior Authorization Ranked Top Barrier to Health Care Access After Cost
2
FDA Flags Administration Concerns for Aquestive's Noninvasive Epinephrine Film
3
Pulmonary Fibrosis and Sexual Health: A Q&A With Na’ama Avitzur, MD
4
Contributor: The Majority (57.5%) of Commercially Insured Patients Had 1 or More Chronic Conditions in 2024
5
